Eledon Pharmaceuticals (FRA:2TK) Ending Cash Position : €6.08 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Eledon Pharmaceuticals Ending Cash Position?

Eledon Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 was €6.08 Mil.

Eledon Pharmaceuticals's quarterly Ending Cash Position increased from Mar. 2024 (€5.20 Mil) to Jun. 2024 (€24.19 Mil) but then declined from Jun. 2024 (€24.19 Mil) to Sep. 2024 (€6.08 Mil).

Eledon Pharmaceuticals's annual Ending Cash Position declined from Dec. 2021 (€75.08 Mil) to Dec. 2022 (€53.25 Mil) and declined from Dec. 2022 (€53.25 Mil) to Dec. 2023 (€4.23 Mil).

Eledon Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Eledon Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eledon Pharmaceuticals Ending Cash Position Chart

Eledon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

7.91

93.87

75.08

53.25

4.23

Eledon Pharmaceuticals Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															3.44	4.23	5.20	24.19	6.08

Eledon Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Eledon Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	51.726	+	-47.497
	=	4.23

Eledon Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	23.462	+	-17.379
	=	6.08

Eledon Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Eledon Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Eledon Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eledon Pharmaceuticals Inc (FRA:2TK) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ELDN:USA 2TK:Germany

Address

19900 MacArthur Boulevard, Suite 550, Irvine, CA, USA, 92612

Website

https://www.eledon.com

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals Headlines

No Headlines